{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:10:53Z","timestamp":1790226653767,"version":"4.1.0"},"reference-count":66,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2025,3,12]]},"DOI":"10.18632\/oncotarget.28703","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T16:02:12Z","timestamp":1741795332000},"page":"140-162","source":"Crossref","is-referenced-by-count":7,"title":["Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients"],"prefix":"10.18632","volume":"16","author":[{"given":"Wafik S.","family":"El-Deiry","sequence":"first","affiliation":[{"name":"Worldwide Innovative Network (WIN) Association - WIN Consortium, Chevilly-Larue, France"},{"name":"Legorreta Cancer Center at Brown University, Providence, RI 02912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bresson","sequence":"additional","affiliation":[{"name":"Worldwide Innovative Network (WIN) Association - WIN Consortium, Chevilly-Larue, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Wunder","sequence":"additional","affiliation":[{"name":"Worldwide Innovative Network (WIN) Association - WIN Consortium, Chevilly-Larue, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedito A.","family":"Carneiro","sequence":"additional","affiliation":[{"name":"Legorreta Cancer Center at Brown University, Providence, RI 02912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don S.","family":"Dizon","sequence":"additional","affiliation":[{"name":"Legorreta Cancer Center at Brown University, Providence, RI 02912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy L.","family":"Warner","sequence":"additional","affiliation":[{"name":"Legorreta Cancer Center at Brown University, Providence, RI 02912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Graff","sequence":"additional","affiliation":[{"name":"Legorreta Cancer Center at Brown University, Providence, RI 02912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Azzoli","sequence":"additional","affiliation":[{"name":"Legorreta Cancer Center at Brown University, Providence, RI 02912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Wong","sequence":"additional","affiliation":[{"name":"Legorreta Cancer Center at Brown University, Providence, RI 02912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Legorreta Cancer Center at Brown University, Providence, RI 02912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sendurai A.","family":"Mani","sequence":"additional","affiliation":[{"name":"Legorreta Cancer Center at Brown University, Providence, RI 02912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard P.","family":"Safran","sequence":"additional","affiliation":[{"name":"Legorreta Cancer Center at Brown University, Providence, RI 02912, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Williams","sequence":"additional","affiliation":[{"name":"Avera Cancer Institute, Sioux Falls, SD 57105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Meissner","sequence":"additional","affiliation":[{"name":"Avera Cancer Institute, Sioux Falls, SD 57105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Solomon","sequence":"additional","affiliation":[{"name":"Avera Cancer Institute, Sioux Falls, SD 57105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Rubin","sequence":"additional","affiliation":[{"name":"Ben-Gurion University of the Negev, Be'er Sheva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Porgador","sequence":"additional","affiliation":[{"name":"Ben-Gurion University of the Negev, Be'er Sheva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Berchem","sequence":"additional","affiliation":[{"name":"Centre Hospitalier du Luxembourg, Luxembourg"},{"name":"University of Luxembourg, Esch-sur-Alzette, Luxembourg"},{"name":"Luxembourg Institute of Health, Luxembourg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Saintigny","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon, France"},{"name":"University of Lyon, Claude Bernard Lyon 1 University, INSERM 1052, CNRS 5286, Centre L\u00e9on B\u00e9rard, Cancer Research Center of Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Onn","sequence":"additional","affiliation":[{"name":"Jusidman Cancer Center, Sheba Medical Center, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair","family":"Bar","sequence":"additional","affiliation":[{"name":"Jusidman Cancer Center, Sheba Medical Center, Ramat Gan, Israel"},{"name":"Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raanan","family":"Berger","sequence":"additional","affiliation":[{"name":"Jusidman Cancer Center, Sheba Medical Center, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Gantenbein","sequence":"additional","affiliation":[{"name":"Luxembourg Institute of Health, Luxembourg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano de P\u00e1dua","family":"Souza","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Manuel Vieira","family":"Reis","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil"},{"name":"Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Sekacheva","sequence":"additional","affiliation":[{"name":"I.M Sechenov First Medical State University, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Cervantes","sequence":"additional","affiliation":[{"name":"INCLIVA Instituto de Investigaci\u00f3n Sanitaria, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Dahut","sequence":"additional","affiliation":[{"name":"American Cancer Society, Atlanta, Georgia, MD 21742, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Annunziata","sequence":"additional","affiliation":[{"name":"American Cancer Society, Atlanta, Georgia, MD 21742, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri","family":"Gober","sequence":"additional","affiliation":[{"name":"American Cancer Society, Atlanta, Georgia, MD 21742, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled M.","family":"Musallam","sequence":"additional","affiliation":[{"name":"Burjeel Medical City (BMC), Mohamed Bin Zayed City, Abu Dhabi, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humaid O.","family":"Al-Shamsi","sequence":"additional","affiliation":[{"name":"Burjeel Medical City (BMC), Mohamed Bin Zayed City, Abu Dhabi, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Abu-Gheida","sequence":"additional","affiliation":[{"name":"Burjeel Medical City (BMC), Mohamed Bin Zayed City, Abu Dhabi, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Salazar","sequence":"additional","affiliation":[{"name":"Medical Oncology Deparment. Institut Catal\u00e0 d'Oncologia. Oncobell Program (IDIBELL), Universitat de Barcelona (Campus Bellvitge), CIBERONC, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sewanti","family":"Limaye","sequence":"additional","affiliation":[{"name":"Sir H.N. Reliance Foundation Hospital and Research Centre, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel T.","family":"Aref","sequence":"additional","affiliation":[{"name":"ProCan, Children\u2019s Medical Research Institute, The University of Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger R.","family":"Reddel","sequence":"additional","affiliation":[{"name":"ProCan, Children\u2019s Medical Research Institute, The University of Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ussama Al","family":"Homsi","sequence":"additional","affiliation":[{"name":"National Center for Cancer Care and Research Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Rouf","sequence":"additional","affiliation":[{"name":"National Center for Cancer Care and Research Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Dermime","sequence":"additional","affiliation":[{"name":"National Center for Cancer Care and Research Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jassim Al","family":"Suwaidi","sequence":"additional","affiliation":[{"name":"National Center for Cancer Care and Research Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalin","family":"Vlad","sequence":"additional","affiliation":[{"name":"Oncology Institute Ion Chiricuta, Cluj, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rares","family":"Buiga","sequence":"additional","affiliation":[{"name":"Oncology Institute Ion Chiricuta, Cluj, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal Al","family":"Omari","sequence":"additional","affiliation":[{"name":"King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmat","family":"Abdel-Razeq","sequence":"additional","affiliation":[{"name":"King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"O\u00f1ate-Oca\u00f1a","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cancerolog\u00eda (INCan), Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn Cilius","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Graham","sequence":"additional","affiliation":[{"name":"The Jackson Laboratory, The Maine Cancer Genomics Initiative, Bar Harbor, ME 04609, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Rueter","sequence":"additional","affiliation":[{"name":"The Jackson Laboratory, The Maine Cancer Genomics Initiative, Bar Harbor, ME 04609, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Joshua","sequence":"additional","affiliation":[{"name":"The Kinghorn Cancer Centre, St Vincent\u2019s Hospital, Darlinghurst, Australia"},{"name":"School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Girda","sequence":"additional","affiliation":[{"name":"Rutgers Cancer Institute, New Brunswick, NJ 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Libutti","sequence":"additional","affiliation":[{"name":"Rutgers Cancer Institute, New Brunswick, NJ 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Riedlinger","sequence":"additional","affiliation":[{"name":"Rutgers Cancer Institute, New Brunswick, NJ 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed E.","family":"Salem","sequence":"additional","affiliation":[{"name":"Wake Forest University Health Sciences\/Atrium Health (WFUHS), Winston-Salem, NC 27157, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J.","family":"Farhangfar","sequence":"additional","affiliation":[{"name":"Wake Forest University Health Sciences\/Atrium Health (WFUHS), Winston-Salem, NC 27157, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben A.","family":"Mesa","sequence":"additional","affiliation":[{"name":"Wake Forest University Health Sciences\/Atrium Health (WFUHS), Winston-Salem, NC 27157, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishoy M.","family":"Faltas","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Elemento","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Pramesh","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Sengar","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Aoyama","sequence":"additional","affiliation":[{"name":"Institute of Science Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadakatsu","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Institute of Science Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Berindan-Neagoe","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy Iuliu Hatieganu, Cluj, Romania"},{"name":"Academy of Medical Sciences, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himabindu","family":"Gaddipati","sequence":"additional","affiliation":[{"name":"Vyas Cancer Research (VCR Park), Maharanipeta, Visakhpatnam, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandar","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Vyas Cancer Research (VCR Park), Maharanipeta, Visakhpatnam, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Auzias","sequence":"additional","affiliation":[{"name":"Cure51, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gerogianni","sequence":"additional","affiliation":[{"name":"Cure51, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wolikow","sequence":"additional","affiliation":[{"name":"Cure51, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Istolainen","sequence":"additional","affiliation":[{"name":"Cure51, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pessie","family":"Schlafrig","sequence":"additional","affiliation":[{"name":"CHAIM Medical Resource Organization, NY 10950, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naftali Z.","family":"Frankel","sequence":"additional","affiliation":[{"name":"CHAIM Medical Resource Organization, NY 10950, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda R.","family":"Ferraro","sequence":"additional","affiliation":[{"name":"Cancer is an A*, LLC, Manalapan Township, NJ 07726, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Palma","sequence":"additional","affiliation":[{"name":"TargetCancer Foundation, Cambridge, MA 02139, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro Piris","family":"Gimenez","sequence":"additional","affiliation":[{"name":"Vall d\u2019Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Hernando-Calvo","sequence":"additional","affiliation":[{"name":"Vall d\u2019Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enriqueta","family":"Felip","sequence":"additional","affiliation":[{"name":"Vall d\u2019Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolia M.","family":"Tsimberidou","sequence":"additional","affiliation":[{"name":"The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy S.","family":"Herbst","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Tabernero","sequence":"additional","affiliation":[{"name":"Vall d\u2019Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Schilsky","sequence":"additional","affiliation":[{"name":"The University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[{"name":"ProCan, Children\u2019s Medical Research Institute, The University of Sydney, Australia"},{"name":"The Kinghorn Cancer Centre, St Vincent\u2019s Hospital, Darlinghurst, Australia"},{"name":"School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Lussier","sequence":"additional","affiliation":[{"name":"Worldwide Innovative Network (WIN) Association - WIN Consortium, Chevilly-Larue, France"},{"name":"The University of Utah, Salt Lake City, UT 84112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Raynaud","sequence":"additional","affiliation":[{"name":"Worldwide Innovative Network (WIN) Association - WIN Consortium, Chevilly-Larue, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Batist","sequence":"additional","affiliation":[{"name":"Segal Cancer Centre, Jewish Hospital, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shai","family":"Magidi","sequence":"additional","affiliation":[{"name":"Worldwide Innovative Network (WIN) Association - WIN Consortium, Chevilly-Larue, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razelle","family":"Kurzrock","sequence":"additional","affiliation":[{"name":"Worldwide Innovative Network (WIN) Association - WIN Consortium, Chevilly-Larue, France"},{"name":"Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"7","author":"Jemal","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"7","author":"Jemal","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"14","author":"Weinberg","year":"2011","journal-title":"Cell"},{"key":"4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3322\/caac.21844","article-title":"The evolving landscape of tissue-agnostic therapies in precision oncology","volume":"7","author":"Kurzrock","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"5","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.1158\/1078-0432.CCR-12-1627","article-title":"Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative","volume":"1","author":"Kurzrock","year":"2012","journal-title":"Clin Cancer Res"},{"key":"6","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cell.2016.12.015","article-title":"Implementing Genome-Driven Oncology","volume":"16","author":"Baselga","year":"2017","journal-title":"Cell"},{"key":"7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.annonc.2022.07.010","article-title":"Cancer: slaying the nine-headed Hydra","volume":"3","author":"Kurzrock","year":"2023","journal-title":"Ann Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41591-019-0424-4","article-title":"Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial","volume":"2","author":"Miller","year":"2019","journal-title":"Nat Med"},{"key":"9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41591-019-0407-5","article-title":"Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study","volume":"2","author":"Webster","year":"2019","journal-title":"Nat Med"},{"key":"10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13073-021-00969-w","article-title":"Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-na\u00efve study","volume":"1","author":"Krie","year":"2021","journal-title":"Genome Med"},{"key":"11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41568-022-00529-3","article-title":"The coming decade in precision oncology: six riddles","volume":"2","author":"Kurzrock","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"12","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"4","author":"Stuart","year":"2013","journal-title":"Nat Genet"},{"key":"13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","article-title":"Proteogenomics connects somatic mutations to signalling in breast cancer","volume":"53","author":"Krug","year":"2016","journal-title":"Nature"},{"key":"14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer","volume":"17","author":"Wong","year":"2018","journal-title":"Cell"},{"key":"15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"57","author":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","journal-title":"Nature"},{"key":"16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3322\/caac.21560","article-title":"The current state of molecular testing in the treatment of patients with solid tumors, 2019","volume":"6","author":"Marshall","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"17","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1200\/EDBK_175524","article-title":"Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come?","volume":"3","author":"Neal","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/bfgp\/elae013","article-title":"A comprehensive review of machine learning techniques for multi-omics data integration: challenges and applications in precision oncology","volume":"2","author":"Mukhopadhyay","year":"2024","journal-title":"Brief Funct Genomics"},{"key":"19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","article-title":"Machine learning applications in cancer prognosis and prediction","volume":"1","author":"Fotiadis","year":"2014","journal-title":"Comput Struct Biotechnol J"},{"key":"20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1200\/JCO-24-01534","article-title":"Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials","volume":"4","author":"Adashek","year":"2025","journal-title":"J Clin Oncol"},{"key":"21","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1002\/cam4.4635","article-title":"A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer","volume":"1","author":"Bresson","year":"2022","journal-title":"Cancer Med"},{"key":"22","doi-asserted-by":"publisher","first-page":"14139","DOI":"10.18632\/oncotarget.3741","article-title":"A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer","volume":"6","author":"Vielh","year":"2015","journal-title":"Oncotarget"},{"key":"23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41698-021-00171-6","article-title":"Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival","volume":"5","author":"Sekacheva","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"24","doi-asserted-by":"publisher","first-page":"e2200072","DOI":"10.1200\/PO.22.00072","article-title":"Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies","volume":"6","author":"Chen","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"25","doi-asserted-by":"publisher","first-page":"17588359221133893","DOI":"10.1177\/17588359221133893","article-title":"Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high-expressing normal lung","volume":"1","author":"Al-Omari","year":"2022","journal-title":"Ther Adv Med Oncol"},{"key":"26","doi-asserted-by":"publisher","first-page":"17588359231156382","DOI":"10.1177\/17588359231156382","article-title":"A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology","volume":"1","author":"Batist","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"27","doi-asserted-by":"publisher","first-page":"17588359241289200","DOI":"10.1177\/17588359241289200","article-title":"Identification of a central network hub of key prognostic genes based on correlation between transcriptomics and survival in patients with metastatic solid tumors","volume":"1","author":"Cilius Nielsen","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Abstracts Presented at the 2024 WIN Symposium in Partnership with Burjeel Holdings: March 1-2, 2024, Abu Dhabi, United Arab Emirates. J Immunother Precis Oncol. 2024; 7:217-41. https:\/\/doi.org\/10.36401\/JIPO-24-X2.","DOI":"10.36401\/JIPO-24-X2"},{"key":"29","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1093\/annonc\/mdv191","article-title":"Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial","volume":"2","author":"Mendelsohn","year":"2015","journal-title":"Ann Oncol"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.e13566","article-title":"Evaluating Clinical Trial Inclusion\/Exclusion Criteria from Claims Using Generative Artificial Intelligence","volume":"4","author":"Noble","year":"2023","journal-title":"J Clin Oncol"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.e13587","article-title":"Digital Trial Solutions escreening: Software to rank patients by their predicted clinical trial eligibility using real-world data and machine learning","volume":"4","author":"Mueller","year":"2023","journal-title":"J Clin Oncol"},{"key":"32","doi-asserted-by":"publisher","first-page":"eadg2809","DOI":"10.1126\/sciadv.adg2809","article-title":"Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer","volume":"9","author":"Rouvinov","year":"2023","journal-title":"Sci Adv"},{"key":"33","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","article-title":"PersonalizedandCancer Models to Guide Precision Medicine","volume":"7","author":"Cheung","year":"2017","journal-title":"Cancer Discov"},{"key":"34","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1200\/JCO.2020.38.15_suppl.3630","article-title":"Predictive value of a CLIA-approved organoid based drug sensitivity test","volume":"3","author":"Gadi","year":"2020","journal-title":"J Clin Oncol"},{"key":"35","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1158\/1078-0432.CCR-20-0073","article-title":"Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy","volume":"2","author":"Hewett","year":"2020","journal-title":"Clin Cancer Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1038\/s41467-018-04495-z","article-title":"Patient derived organoids to model rare prostate cancer phenotypes","volume":"9","author":"Sailer","year":"2018","journal-title":"Nat Commun"},{"key":"37","doi-asserted-by":"publisher","first-page":"e2100489","DOI":"10.1200\/PO.21.00489","article-title":"Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates","volume":"7","author":"Hundal","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"38","doi-asserted-by":"publisher","first-page":"1267650","DOI":"10.3389\/fonc.2023.1267650","article-title":"Case report:tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinoma","volume":"1","author":"Grandori","year":"2024","journal-title":"Front Oncol"},{"key":"39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41698-023-00379-8","article-title":"Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing","volume":"7","author":"Margossian","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"40","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cell.2015.01.042","article-title":"Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy","volume":"16","author":"Cichowski","year":"2015","journal-title":"Cell"},{"key":"41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ajh.25692","article-title":"Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re-induction chemotherapy","volume":"9","author":"Stone","year":"2020","journal-title":"Am J Hematol"},{"key":"42","doi-asserted-by":"publisher","first-page":"eaay1451","DOI":"10.1126\/scisignal.aay1451","article-title":"High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors","volume":"1","author":"Aguirre","year":"2020","journal-title":"Sci Signal"},{"key":"43","doi-asserted-by":"publisher","first-page":"e202302146","DOI":"10.26508\/lsa.202302146","article-title":"Proteomic-based stratification of intermediate-risk prostate cancer patients","volume":"7","author":"Ding","year":"2023","journal-title":"Life Sci Alliance"},{"key":"44","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1158\/1538-7445.AM2023-2209","article-title":"A proteomic-based prognostic signature of pancreatic adenocarcinoma","volume":"8","author":"Lucas","year":"2023","journal-title":"Cancer Res"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Habib, Aref, Anees, Pathan, McLeod, Balleine, Bucio-Noble, Noor, Ma, Wang, Heads, Lalee, Loudon, et al. A 19-Protein Signature to Predict Outcomes in a Cohort of Stage II and III CRC. 2023; 41. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.3129.","DOI":"10.1200\/JCO.2023.41.16_suppl.3129"},{"key":"46","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.1158\/1538-7445.AM2023-5479","article-title":"A six-protein signature predicts response and survival in patients with advanced cutaneous melanoma treated with immunotherapy","volume":"8","author":"Newell","year":"2023","journal-title":"Cancer Res"},{"key":"47","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1158\/1538-7445.AM2023-5391","article-title":"Machine learning of cancer type and tissue of origin from proteomes of 1,277 human tissue samples and 975 cancer cell lines","volume":"8","author":"Reddel","year":"2023","journal-title":"Cancer Res"},{"key":"48","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1200\/JCO.2023.41.16_suppl.3120","article-title":"Pan-cancer diagnostic proteomic signature of tissue-of-origin (TOO) using data-independent acquisition mass spectrometry (DIA-MS) from 1289 human tissue samples","volume":"4","author":"Hains","year":"2023","journal-title":"J Clin Oncol"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1101\/2022.02.26.482008","article-title":"Pan-cancer proteomic map of 949 human cell lines reveals principles of cancer vulnerabilities","author":"Cai","year":"2022","journal-title":"bioRxiv"},{"key":"50","doi-asserted-by":"crossref","DOI":"10.17226\/27149","volume-title":"Toward Sequencing and Mapping of RNA Modifications: Proceedings of a Workshop\u2014in Brief","author":"Moss","year":"2023"},{"key":"51","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41588-021-00903-1","article-title":"A call for direct sequencing of full-length RNAs to identify all modifications","volume":"5","author":"Ross","year":"2021","journal-title":"Nat Genet"},{"key":"52","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.3390\/cancers13143600","article-title":"Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening","volume":"1","author":"Kurzrock","year":"2021","journal-title":"Cancers (Basel)"},{"key":"53","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1158\/1078-0432.CCR-17-0454","article-title":"Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine","volume":"2","author":"Kurzrock","year":"2017","journal-title":"Clin Cancer Res"},{"key":"54","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1158\/1535-7163.MCT-18-0535","article-title":"Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients","volume":"1","author":"Kurzrock","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"55","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1056\/NEJMoa2402604","article-title":"Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma","volume":"39","author":"Torres Acosta","year":"2024","journal-title":"N Engl J Med"},{"key":"56","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1056\/NEJMoa2211437","article-title":"Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma","volume":"38","author":"Sosman","year":"2023","journal-title":"N Engl J Med"},{"key":"57","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1038\/s41591-024-03250-w","article-title":"Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial","volume":"3","author":"Oosterling","year":"2024","journal-title":"Nat Med"},{"key":"58","unstructured":"Project FrontRunner - Advancing Development of Oncology Therapies to the Early Clinical Setting. 2024. https:\/\/www.fda.gov\/about-fda\/oncology-center-excellence\/project-frontrunner."},{"key":"59","unstructured":"For Physicians: How to Request Single Patient Expanded Access (\u201cCompassionate Use\u201d). 2024. https:\/\/www.fda.gov\/drugs\/investigational-new-drug-ind-application\/physicians-how-request-single-patient-expanded-access-compassionate-use."},{"key":"60","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/jamaoncol.2017.5618","article-title":"A 25-Year Experience of US Food and Drug Administration Accelerated Approval of Malignant Hematology and Oncology Drugs and Biologics: A Review","volume":"4","author":"Kluetz","year":"2018","journal-title":"JAMA Oncol"},{"key":"61","doi-asserted-by":"publisher","first-page":"102703","DOI":"10.1016\/j.ctrv.2024.102703","article-title":"Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design","volume":"12","author":"Kurzrock","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"62","doi-asserted-by":"publisher","first-page":"102019","DOI":"10.1016\/j.ctrv.2020.102019","article-title":"Review of precision cancer medicine: Evolution of the treatment paradigm","volume":"8","author":"Kurzrock","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"63","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41591-022-01931-y","article-title":"Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1\/2 ARROW trial","volume":"2","author":"Chang","year":"2022","journal-title":"Nat Med"},{"key":"64","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1093\/annonc\/mdy137","article-title":"Selective RET kinase inhibition for patients with RET-altered cancers","volume":"2","author":"Burkard","year":"2018","journal-title":"Ann Oncol"},{"key":"65","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1159\/000533866","article-title":"The Potential of Trastuzumab Deruxtecan as a Tissue Agnostic Drug","volume":"10","author":"J\u00f8rgensen","year":"2023","journal-title":"Oncology"},{"key":"66","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","article-title":"Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study","volume":"2","author":"Piha-Paul","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T16:02:15Z","timestamp":1741795335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3,12]]}},"alternative-id":["28703"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28703","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]}}}